IP Verse

Expression System

PatentPatent Analysis

EP3480209

GLAXOSMITHKLINE BIOLOGICALS
Application Number
EP18167370A
Filing Date
Oct 7, 2010
Status
Granted And Under Opposition
Oct 27, 2023
Grant Date
Nov 29, 2023
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3564378B1
EP4066819B1
EP4043040B1

Bibliography

The patent EP3480209B1 was granted to Glaxosmithkline Biologicals on Nov 29, 2023 following the initial filing on Oct 7, 2010 under the application number EP18167370A . The current legal status of the patent is Granted And Under Opposition.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions filed by Competitors

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

ARGYMAAug 29, 2024 -

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents